The FDA has extended for 30 days the comment period for its proposed 510(k) pathway changes, setting the new deadline at May 22. The proposal seeks to discourage the use of older predicates by releasing a list of medical devices that were based on predicates over a decade old.
FDA extends comment period for 510(k) revamp proposal
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.